- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 253/10 - Condensed 1,2,4-triazinesHydrogenated condensed 1,2,4-triazines
Patent holdings for IPC class C07D 253/10
Total number of patents in this class: 30
10-year publication summary
|
3
|
3
|
0
|
2
|
0
|
2
|
2
|
2
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Japan Tobacco Inc. | 3488 |
3 |
| Bayer HealthCare LLC | 1383 |
2 |
| Takeda Pharmaceutical Company Limited | 2943 |
2 |
| Bristol-myers Squibb Company | 4863 |
1 |
| LG Display Co., Ltd. | 12892 |
1 |
| The Regents of the University of California | 19517 |
1 |
| Merck Sharp & Dohme Corp. | 2219 |
1 |
| Dow Global Technologies LLC | 10156 |
1 |
| Abbvie Inc. | 1782 |
1 |
| OSRAM Opto Semiconductors GmbH | 3336 |
1 |
| Alios BioPharma, Inc. | 67 |
1 |
| Auckland UniServices Limited | 498 |
1 |
| BioCryst Pharmaceuticals, Inc. | 176 |
1 |
| Incyte Corporation | 963 |
1 |
| SRI International | 1000 |
1 |
| Stichting Maastricht Radiation Oncology "maastro-clinic" | 17 |
1 |
| Trustees of Dartmouth College | 1061 |
1 |
| Universite de Montpellier | 960 |
1 |
| University of Greenwich | 73 |
1 |
| Istanbul Medipol Universitesi | 149 |
1 |
| Other owners | 6 |